← Evidence map

ArticleFrontiers in pharmacology2023

Vitamin D3 alleviates nonalcoholic fatty liver disease in rats by inhibiting hepatic oxidative stress and inflammation via the SREBP-1-c/ PPARα-NF-κB/IR-S2 signaling pathway.

Doha Reda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37261280